MENU
MIRM
AS OF
Dec 24 closing price
Price
$80.75
Change
+$0.70 (+0.87%)
Capitalization
4.17B
76 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
MIRM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Mirum Pharmaceuticals (MIRM) Ownership - Who owns Mirum Pharmaceuticals?

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
950 Tower Lane
Phone
+1 650 667-4085
Employees
264
Web
https://www.mirumpharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.17B
P/E Ratio
N/A
Total Cash
375.55M
Projected Growth
N/A
Total Debt
318.76M
Revenue
471.79M
Risk (Beta)
0.92
Dividend Yield
N/A
Total Cash/Share
7.27
Total Debt/Equity
N/A
Revenue/Share
9.56 USD as % of share price

Fundamentals

MIRM
Capitalization
4.17B
P/E Ratio
N/A
Risk (Beta)
0.92
Dividend Yield
N/A
Total Cash
376M
Total Cash/Share
7.27
Total Debt
319M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
9.56%
Revenue
472M
ROE
N/A
Book Value
292M
P/B Ratio
14.29
Cash Flow
N/A
Earnings
-0.84
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
3.31
Current Revenue Per Employee
374676.06
Dividends Per Share - Security
N/A
EBITDA
-2.23M
Float
N/A
Float - Current
N/A
Gross Income Margin
80.80
Revenue To Assets
-5.70
Shares Held By Institutions
6.38B
Shares Outstanding - Current
51.7M
Total Liabilities
493M
Total Volume MTD
N/A
Value
N/A
Gain YTD
95.284
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
MIRM
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MIRM showed earnings on November 04, 2025. You can read more about the earnings report here.
View AI-Driven Trading for MIRM
A.I. Advisor
published General Information

General Information

a biopharmaceutical company. which focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
950 Tower Lane
Phone
+1 650 667-4085
Employees
264
Web
https://www.mirumpharma.com